Postchemoembolisation syndrome--tumour necrosis or hepatocyte injury?

作者: S J Wigmore , D N Redhead , B N J Thomson , E J Currie , R W Parks

DOI: 10.1038/SJ.BJC.6601329

关键词: HepatocytePathologyChemotherapyMetastasisTransaminaseHepatocellular carcinomaMedicineLiver function testsCytolysisNecrosis

摘要: Transarterial chemoembolisation of liver tumours is typically followed by elevated body temperature and transaminase enzymes. This has often been considered to indicate successful embolisation. The present study questions whether this syndrome reflects damage tumour cells or the normal hepatic tissue. responses 256 embolisations undertaken in 145 patients subdivided into those with hepatocyte-derived (primary hepatocellular carcinoma) nonhepatocyte-derived (secondary metastases) were analysed assess relative effects necrosis hepatocytes each group. Cytolysis, measured alanine aminotransferase, was detected 85% patients, there no difference abnormalities function tests between two groups. Furthermore, cytolysis associated a higher rate postprocedure symptoms side effects, worse survival on univariate analysis. Multivariate analysis demonstrated that benefit terms from having following Cytolysis after probably due hepatocytes. Temperature changes may reflect healthy There evidence either postchemoembolisation fever an enhanced response improved long-term primary secondary cancer.

参考文章(15)
Deng-Yn Lin, Yun-Fan Liaw, Tse-Yu Lee, Chi-Ming Lai, Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma—A randomized controlled trial Gastroenterology. ,vol. 94, pp. 453- 456 ,(1988) , 10.1016/0016-5085(88)90436-2
J W Chung, J H Park, J K Han, B I Choi, M C Han, H S Lee, C Y Kim, Hepatic tumors: predisposing factors for complications of transcatheter oily chemoembolization. Radiology. ,vol. 198, pp. 33- 40 ,(1996) , 10.1148/RADIOLOGY.198.1.8539401
Thomas Lehnert, Christian Herfarth, Chemoembolization for hepatocellular carcinoma. What, when, and for whom? Annals of Surgery. ,vol. 224, pp. 1- 3 ,(1996) , 10.1097/00000658-199607000-00001
Toshiro Harada, Katsuichi Matsuo, Takato Inoue, Satoshi Tamesue, Toshitaka Inoue, Hideharu Nakamura, Is Preoperative Hepatic Arterial Chemoembolization Safe and Effective for Hepatocellular Carcinoma Annals of Surgery. ,vol. 224, pp. 4- 9 ,(1996) , 10.1097/00000658-199607000-00002
François Paye, Pascal Jagot, Valérie Vilgrain, Olivier Farges, Dominique Borie, Jacques Belghiti, Preoperative Chemoembolization of Hepatocellular Carcinoma Archives of Surgery. ,vol. 133, pp. 767- 772 ,(1998) , 10.1001/ARCHSURG.133.7.767
Kenji Takenaka, Kisaku Yoshida, Takashi Nishizaki, Daisuke Korenaga, Kaichiro Hiroshige, Toshihiko Ikeda, Keizo Sugimachi, Postoperative prophylactic lipiodolization reduces the intrahepatic recurrence of hepatocellular carcinoma The American Journal of Surgery. ,vol. 169, pp. 400- 405 ,(1995) , 10.1016/S0002-9610(99)80184-6
Douglas G. Farmer, Michael H. Rosove, Abraham Shaked, Ronald W. Busuttil, Current treatment modalities for hepatocellular carcinoma Annals of Surgery. ,vol. 219, pp. 236- 247 ,(1994) , 10.1097/00000658-199403000-00003
Cai-De Lu, Shu-You Peng, Xien-Chuan Jiang, Yukio Chiba, Nobuhiko Tanigawa, Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinomas: retrospective analysis of 120 cases. World Journal of Surgery. ,vol. 23, pp. 293- 300 ,(1999) , 10.1007/PL00013185